This condition is often related to liver cirrhosis and requires immediate medical attention
Once-weekly subcutaneous semaglutide 2.4 mg is approved for weight management in people with obesity and related complications
Traveling with tirzepatide: thigh injection on the go Maintaining your injection schedule while traveling adds logistical challenges
Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)